期刊
CELL CYCLE
卷 7, 期 16, 页码 2493-2499出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/cc.7.16.6452
关键词
microRNA; oncogene; tumor suppressor; c-Myc; p53; nuclear factor kappa B; fusion oncoprotein; gene expression
类别
资金
- National Institutes of Health [R01 CA120185]
- Sol Goldman Pancreatic Cancer Research Center
A large body of evidence has documented abnormal microRNA (miRNA) expression patterns in diverse human malignancies. Given that miRNA expression is tightly regulated during development and cellular differentiation, aberrant miRNA expression in cancer cells is likely to be in part a consequence of the loss of normal cellular identity that accompanies malignant transformation. Nevertheless, it is now clear that miRNAs function as critical effectors of several canonical oncogenic and tumor suppressor pathways, including those controlled by Myc and p53. Gain- and loss-of-function of these factors in cancer cells contributes to miRNA dysregulation, directly influencing neoplastic phenotypes including cellular proliferation and apoptosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据